Abstract:Although guidelines provide excellent expert guidance for managing patients with septic shock, they leave room for personalization according to patients' condition. Hemodynamic monitoring depends on the evolution phase: salvage, optimization, stabilization, and de-escalation. Initially during the salvage phase, monitoring to identify shock etiology and severity should include arterial pressure and lactate measurements together with clinical examination, particularly skin mottling and capillary refill time. Low diastolic blood pressure may trigger vasopressor initiation. At this stage, echocardiography may be useful to identify significant cardiac dysfunction. During the optimization phase, echocardiographic monitoring should be pursued and completed by the assessment of tissue perfusion through central or mixed-venous oxygen saturation, lactate, and carbon dioxide veno-arterial gradient. Transpulmonary thermodilution and the pulmonary artery catheter should be considered in the most severe patients. Fluid therapy also depends on shock phases. While administered liberally during the resuscitation phase, fluid responsiveness should be assessed during the optimization phase. During stabilization, fluid infusion should be minimized. In the de-escalation phase, safe fluid withdrawal could be achieved by ensuring tissue perfusion is preserved. Norepinephrine is recommended as first-line vasopressor therapy, while vasopressin may be preferred in some patients. Essential questions remain regarding optimal vasopressor selection, combination therapy, and the most effective and safest escalation. Serum renin and the angiotensin I/II ratio may identify patients who benefit most from angiotensin II. The optimal therapeutic strategy for shock requiring high-dose vasopressors is scant. In all cases, vasopressor therapy should be individualized, based on clinical evaluation and blood flow measurements to avoid excessive vasoconstriction. Inotropes should be considered in patients with decreased cardiac contractility associated with impaired tissue perfusion. Based on pharmacologic properties, we suggest as the first test a limited dose of dobutamine, to add enoximone or milrinone in the second line and substitute or add levosimendan if inefficient. Regarding adjunctive therapies, while hydrocortisone is nowadays advised in patients receiving high doses of vasopressors, patients responding to corticosteroids may be identified in the future by the analysis of selected cytokines or specific transcriptomic endotypes. To conclude, although some general rules apply for shock management, a personalized approach should be considered for hemodynamic monitoring and support.

Extensive Variability in Vasoactive Agent Therapy

Abstract 18546: Vasoactive Medication Variability in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock

Vasopressor Therapy in the Intensive Care Unit

Vasoactive Agents for the Treatment of Sepsis.

Vasoactive pharmacologic therapy in cardiogenic shock: a critical review

Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials

The Clinical Application of Different Vasoactive Drugs in the Treatment of Septic Shock

Evaluation of Vasoactive Agents on Microcirculatory Disturbance in Shock Patients

Vasopressors in Septic Shock: a Systematic Review and Network Meta-Analysis.

Prognosis of Patients with Shock Receiving Vasopressors.

INITIATION TIMING OF VASOPRESSOR IN PATIENTS WITH SEPTIC SHOCK: A SYSTEMATIC REVIEW AND META-ANALYSIS

Clinical Efficiency of Vasopressin or Its Analogs in Comparison with Catecholamines Alone on Patients with Septic Shock: A Systematic Review and Meta-Analysis.

The Usage of Concomitant Beta-Blockers with Vasopressors and Inotropes in Cardiogenic Shock

A plea for personalization of the hemodynamic management of septic shock

Hospital Variability in the Use of Vasoactive Agents in Patients Hospitalized for Acute Decompensated Heart Failure: Clinical Phenotypes and Therapeutic Approaches

Effect of vasopressor on hemodynamics and quality of life in patients with septic shock

An Email-Based Survey of Treatment Strategies in Children with Septic Shock in China

Knowledge of and Compliance with Surviving Sepsis Campaign Guidelines among Anesthesiologists: A Nationwide Survey in China

[Effect of Dopamine and Norepinephrine on Hemodynamics and Tissue Oxygenation of Patients with Septic Shock].

Central Venous-To-Arterial Carbon Dioxide Partial Pressure Difference As A Guiding Parameter For Cardiotonic Drug Administration In Patients With Early-Stage Septic Shock

An Email-Based Survey of Practice Regarding Hemodynamic Monitoring and Management in Children with Septic Shock in China